3-43081068-C-T
Variant summary
Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2
The NM_032806.6(POMGNT2):c.364G>A(p.Val122Met) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.000689 in 1,614,194 control chromosomes in the GnomAD database, including 9 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. V122L) has been classified as Uncertain significance.
Frequency
Consequence
NM_032806.6 missense
Scores
Clinical Significance
Conservation
Publications
- muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type a, 8Inheritance: AR Classification: DEFINITIVE, STRONG, MODERATE Submitted by: Genomics England PanelApp, Labcorp Genetics (formerly Invitae), G2P, Ambry Genetics
- myopathy caused by variation in POMGNT2Inheritance: AR Classification: DEFINITIVE Submitted by: ClinGen
- muscular dystrophy-dystroglycanopathy, type AInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Our verdict: Benign. The variant received -20 ACMG points.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| POMGNT2 | NM_032806.6 | c.364G>A | p.Val122Met | missense_variant | Exon 2 of 2 | ENST00000344697.3 | NP_116195.2 | |
| POMGNT2 | NM_001437285.1 | c.364G>A | p.Val122Met | missense_variant | Exon 3 of 3 | NP_001424214.1 | ||
| POMGNT2 | XM_011534163.3 | c.364G>A | p.Val122Met | missense_variant | Exon 3 of 3 | XP_011532465.1 | ||
| POMGNT2 | XM_017007353.2 | c.364G>A | p.Val122Met | missense_variant | Exon 4 of 4 | XP_016862842.1 |
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| POMGNT2 | ENST00000344697.3 | c.364G>A | p.Val122Met | missense_variant | Exon 2 of 2 | 1 | NM_032806.6 | ENSP00000344125.2 |
Frequencies
GnomAD3 genomes AF: 0.00320 AC: 487AN: 152196Hom.: 4 Cov.: 33 show subpopulations
GnomAD2 exomes AF: 0.000986 AC: 248AN: 251420 AF XY: 0.000839 show subpopulations
GnomAD4 exome AF: 0.000428 AC: 625AN: 1461880Hom.: 5 Cov.: 37 AF XY: 0.000393 AC XY: 286AN XY: 727242 show subpopulations
Age Distribution
GnomAD4 genome AF: 0.00320 AC: 487AN: 152314Hom.: 4 Cov.: 33 AF XY: 0.00309 AC XY: 230AN XY: 74476 show subpopulations
Age Distribution
ClinVar
Submissions by phenotype
not provided Benign:3
- -
- -
- -
not specified Benign:1
- -
POMGNT2-related disorder Benign:1
This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -
Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type a, 8 Benign:1
- -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at